Yidan Biotech Peptides Review

Finnrick, an independent testing programme, publishes 11 assays for Yidan Biotech: 9 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 2 did not. Most recent assay 5 Aug 2026.

Yidan Biotech listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/yidan-biotech.

Yidan Biotech is listed as active.

Finnrick assay record for Yidan Biotech

ProductAssaysResult
Retatrutide65 passed, 1 failed
Tirzepatide54 passed, 1 failed

Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.

The record for Yidan Biotech

StatusActive
Vendor typeResearch-use supplier

What we found

Ordering and payment

Payment methods
Cryptocurrency, Bank Transfer, Credit Card
Card payments
Accepted
Cryptocurrency
Accepted (USDT, USDC, BTC, ETH)
Bank transfer
Accepted
Currency
AUD
Online checkout
Not available

Shipping and handling

Ships to
United States, Europe, Canada, Australia, Asia, Worldwide

Returns and guarantees

Returns
Refund Policy-Shanghai Yidan Biotechnology Co., Ltd.

Company details

Trading since
2017
Operates from
China
Basis for location
Site copy references China; Pages are served in GB2312, a Chinese-language character encoding; Lists a Hong Kong (+852) contact number

Contact channels

Email
[email protected]
Phone
+85268505312
Contact page
https://yidanbio.com/Contact-us.asp
Messaging
WhatsApp

How we checked

These details were read from Yidan Biotech's own website on 2026-08-17. Pages consulted:

Frequently asked questions

Is Yidan Biotech legit?

Yidan Biotech is listed as active and we hold 11 Finnrick assays (9 passing, 2 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.

Has Yidan Biotech been lab tested?

Yes. Finnrick, an independent testing programme, publishes 11 assays for Yidan Biotech: 9 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 2 did not. Most recent assay 5 Aug 2026.

Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.

Other reviewed vendors: Yimei Peptides Review, Yiwu Aozuo Trading Co Peptides Review, Yiwu Aozuo Trading Firm Peptides Review.